Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 3,888 | 5,205 | 4,628 | 6,085 |
| Gross Profit | N/A | 3,888 | 5,205 | 4,628 | 6,085 |
| Operating Expenses | 80,334 | 49,351 | 32,881 | 26,534 | 17,400 |
| Operating Income | -80,334 | -45,463 | -27,676 | -21,906 | -11,315 |
| Other Income | 2,080 | 1,115 | 440 | 208 | 20 |
| Pre-tax Income | -78,254 | -44,348 | -27,236 | -21,698 | -11,295 |
| Net Income Continuous | -78,254 | -44,348 | -27,236 | -21,698 | -11,295 |
| Net Income | $-78,254 | $-44,348 | $-27,236 | $-21,698 | $-11,295 |
| EPS Basic Total Ops | -61.25 | -53.25 | -45.00 | -55.50 | -480.25 |
| EPS Basic Continuous Ops | -61.23 | -53.24 | -45.01 | -55.40 | -470.79 |
| EPS Diluted Total Ops | -61.25 | -53.25 | -45.00 | -55.50 | -480.25 |
| EPS Diluted Continuous Ops | -61.23 | -53.24 | -45.01 | -55.40 | -470.79 |
| EPS Diluted Before Non-Recurring Items | -61.25 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-80,734 | $-45,763 | $-27,352 | $-21,673 | $-11,229 |